Keystone Capital Management has announced the formation of Gillson Sciences, a Chicago-based provider of laboratory testing, monitoring, and advisory solutions. This new venture is set to offer science-driven support to clients in the pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences sectors, ensuring their products meet the highest standards of safety and efficacy. The creation of Gillson Sciences marks a significant step forward in addressing complex human health challenges through integrated scientific solutions.
Gillson Sciences was established in January 2025 following the acquisitions of Azzur Labs and Micro Measurement Laboratories, now operating as Gillson Testing. These strategic moves have equipped Gillson with the capabilities to deliver a wide range of services required by regulatory bodies, making it a critical partner for clients navigating the stringent compliance demands of their industries. With laboratories in Pennsylvania, Illinois, and California, and a team of field personnel across the U.S., Gillson is well-positioned to serve its clients nationwide.
Leading the charge as CEO is Jason Fischer, a seasoned executive with a 13-year tenure at UL Solutions, where he held several leadership roles. Fischer's expertise in corporate development and strategic acquisitions is expected to drive Gillson's growth and expansion in the testing, inspection, certification, and compliance sector. Gillson Sciences aims to become a market leader by leveraging its scientific excellence, data integrity, and commitment to customer satisfaction.
The partnership between Keystone Capital and Jason Fischer underscores a shared vision for building a platform that prioritizes quality, safety, and regulatory excellence. Todd Lanscioni, Managing Director at Keystone Capital, expressed confidence in Fischer's leadership and the Gillson team's ability to execute this vision. As Gillson Sciences continues to explore opportunities for expansion, its mission remains clear: to advance human health through premier laboratory testing and advisory services.
This development is particularly important as it comes at a time when the demand for reliable testing and compliance services is at an all-time high, driven by increasing regulatory scrutiny and the need for safe, effective products in the healthcare and environmental sectors. Gillson Sciences is poised to meet these challenges head-on, offering clients the expertise and support they need to succeed in a rapidly evolving landscape.
